Invokana is a type 2 diabetes medication, also known as Canagliflozin, and patients using the drug have suffered from diabetic ketoacidosis, cardiovascular injury, and kidney failure. The Food and Drug Administration (FDA) has warned that the ketoacidosis that occurs is a result of insulin levels dropping too low. Diabetic ketoacidosis usually occurs in those suffering with type 1 diabetes, but now has been found in those with type 2 diabetes while using Invokana.
Invokana is a sodium-glucose-cotransporter-2 (SGLT2) inhibitor. Potential lawsuits are currently being considered against the maker of Invokana. While type 2 diabetes is a condition that has dangerous and potentially side effects without the use of medications, patients would be wise to fully explore what class of drugs are prescribed for this condition and be on the lookout for potentially harmful drugs on the market today.
If you or a loved one has been affected by Invokana, do not hesitate to contact the caring professionals at Inserra & Kelley Law Offices to explore whether you might be a candidate for possible lawsuits and compensation.